exit potential

The exit landscape for healthcare startups is increasingly attractive, driven by strategic M&A, IPO readiness, and private equity roll-ups.

• Strategic Acquisitions: Payers (e.g., UnitedHealth), pharma (e.g., Pfizer), and big tech (e.g., Amazon, Google) are actively acquiring digital health, AI, and care coordination startups to bolster offerings.

• IPO Market: Public investor appetite remains strong for differentiated, high-growth health tech companies with real-world traction.

• PE Buyouts: With healthcare becoming a core sector for private equity, buyouts of mid-stage companies offer strong secondary liquidity opportunities.

We target a 2x return on early-stage investments through rigorous thesis alignment and exit strategy planning.

Download our investment thesis here.